From: Survival associated pathway identification with group L p penalized global AUC maximization
Pathways | # of Genes | Pathways | # of Genes |
---|---|---|---|
Propanoate metabolism | 5 | Melanoma | 10 |
Type II diabetes mellitus | 6 | Thyroid cancer | 5 |
Adipocytokine signaling pathway | 10 | Prostate cancer | 13 |
Melanogenesis | 13 | Glycolysis/Gluconeogenesis | 8 |
GnRH signaling pathway | 11 | Butanoate metabolism | 6 |
Insulin signaling pathway | 15 | Endometrial cancer | 11 |
Sphingolipid metabolism | 5 | Pancreatic cancer | 10 |
Glycerophospholipid metabolism | 9 | Colorectal cancer | 12 |
T cell receptor signaling pathway | 11 | RNA polymerase | 6 |
Hematopoietic cell lineage | 10 | Huntington's disease | 5 |
Glycerolipid metabolism | 6 | Focal adhesion | 20 |
Toll-like receptor signaling pathway | 13 | Apoptosis | 12 |
Antigen processing and presentation | 9 | Adherens junction | 10 |
Complement and coagulation cascades | 8 | Tryptophan metabolism | 7 |
ECM-receptor interaction | 14 | Histidine metabolism | 6 |
Wnt signaling pathway | 20 | Fatty acid metabolism | 10 |
Ubiquitin mediated proteolysis | 15 | Acute myeloid leukemia | 9 |
Neuroactive ligand-receptor interaction | 28 | Bladder cancer | 6 |
gamma-Hexachlorocyclohexane degradation | 5 | Focal adhesion | 20 |
Calcium signaling pathway | 21 | ErbB signaling pathway | 11 |
MAPK signaling pathway | 31 | PPAR signaling pathway | 16 |
Valine, leucine and isoleucine degradation | 6 | Glioma | 7 |
Pyrimidine metabolism | 12 | Chronic myeloid leukemia | 10 |
Glycan structures - degradation | 5 | Non-small cell lung cancer | 11 |
Porphyrin and chlorophyll metabolism | 7 | Â | Â |